Discgenics, Inc. — Form D/A
Discgenics, Inc. of SALT LAKE CITY, UT, a company, filed a Form D amendment with the SEC on 2011-10-21. The offering totals $4.0M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-10-21
- Form: D/A
- Accession: 0001503545-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $4.0M
- Amount sold: $1.8M
- Remaining: $2.2M
- Investors: 17
- Date of first sale: 2010-08-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-149387
Issuer
- Name: Discgenics, Inc.
- CIK: 0001503545
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 675 ARAPEEN DR., SALT LAKE CITY, UT, 84108
- Phone: 801-410-0703
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Mark S Cohen | Director | BLOOMFIELD, CT |
| Christopher D Duntsch, M.D., Ph.D. | Director | Memphis, TN |
| Kevin T Foley, M.D. | Director | Germantown, TN |
| Christopher D Duntsch, M.D., Ph.D. | Executive Officer | Memphis, TN |
| Kevin T Foley, M.D. | Executive Officer | Germantown, TN |
| Mike A Moffat | Executive Officer | Memphis, TN |
| Greg A Ziskind | Executive Officer | Memphis, TN |
| J. Flagg Flanagan | Director | Goleta, CA |
| J. Flagg Flanagan | Executive Officer | Goleta, CA |
| Robert M Wynalek | Director | Draper, UT |
| Robert M Wynalek | Executive Officer | Draper, UT |
| Kevin T Foley | Director | Germantown, TN |
Other filings by this issuer (2)
More